At the immune level, FCN2 may suppress the tumor immune response of HCC by upregulating the entry of neutrophils, eosinophils, NK cells, Tcm, and DCs and downregulating the entry of Th2 into tumors. The gene discussed is FCN2; the disease is neoplasm.